BioSpace News Archive

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that senior management will be participating in investor meetings and a fireside chat at the BofA 2022 Healthcare Conference on Thursday, May, 12, 2022 in Las Vegas, Nevada.

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and first quarter 2022 financial results.

Pharvaris announced that management will present at the BofA Securities 2022 Healthcare Conference taking place in Las Vegas, NV from May 10 – 12, 2022.

Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the first quarter ended March 31, 2022.

Vir Biotechnology, Inc. provided a corporate update and reported financial results for the first quarter ended March 31, 2022.

NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, provided business highlights and reported financial results for the quarterly period ended March 31, 2022.

Eiger BioPharmaceuticals, Inc. reported financial results for first quarter 2022 and provided a business update.

Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, announced recent company highlights and financial results for the first quarter ended March 31, 2022.

Puma Biotechnology, Inc., a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2022.

Gemina Laboratories Ltd. is pleased to announce the successful completion of its human performance study for the Gemina Legio XTM COVID-19 Rapid Antigen test, a significant development milestone demonstrating the power of Gemina’s novel patented chemistry.